amodiaquine has been researched along with Parkinsonian Disorders in 1 studies
Amodiaquine: A 4-aminoquinoline compound with anti-inflammatory properties.
amodiaquine : A quinoline having a chloro group at the 7-position and an aryl amino group at the 4-position.
Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kambey, PA | 1 |
| Chengcheng, M | 1 |
| Xiaoxiao, G | 1 |
| Abdulrahman, AA | 1 |
| Kanwore, K | 1 |
| Nadeem, I | 1 |
| Jiao, W | 1 |
| Gao, D | 1 |
1 other study available for amodiaquine and Parkinsonian Disorders
| Article | Year |
|---|---|
The orphan nuclear receptor Nurr1 agonist amodiaquine mediates neuroprotective effects in 6-OHDA Parkinson's disease animal model by enhancing the phosphorylation of P38 mitogen-activated kinase but not PI3K/AKT signaling pathway.
Topics: Amodiaquine; Animals; Brain; Enzyme Inhibitors; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agen | 2021 |